JESSIE STEPHEN: Open Payments
NPI 1780845842 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 37 payments from 6 companies in 2025. Trend: 2023 $201 · 2024 $386 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $294 |
| Otsuka America Pharmaceutical, Inc. | 9 | $185 |
| ABBVIE INC. | 11 | $150 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
Products named: UZEDY, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, CAPLYTA, COBENFY, ABILIFY MAINTENA, REXULTI.
Industry payments across MD — which companies pay providers there.
